VEGFA and dementia: The aim of the present study was therefore to investigate the potential association between the use of intravitreal anti-VEGF drugs and dementia and Parkinson-related disorders using VigiBase, the World Health Organization (WHO) international spontaneous reporting database, by calculating Proportional Reporting Ratios as a disproportionality measure.